Human SPON1/f-spondin/VSGP/F-spondin ORF/cDNA clone-Lentivirus plasmid (NM_006108)

Cat. No.: pGMLP001799
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human SPON1/f-spondin/VSGP/F-spondin Lentiviral expression plasmid for SPON1 lentivirus packaging, SPON1 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Target products collection

Go to SPON1/f-spondin products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Total Price: $1124.16
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMLP001799
Gene Name SPON1
Accession Number NM_006108
Gene ID 10418
Species Human
Product Type Lentivirus plasmid (overexpression)
Insert Length 2424 bp
Gene Alias f-spondin,VSGP/F-spondin
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGAGGCTGTCCCCGGCGCCCCTGAAGCTGAGCCGGACTCCGGCACTGCTGGCCCTGGCGCTGCCCCTGGCCGCGGCGCTGGCCTTCTCCGACGAGACCCTGGACAAAGTGCCCAAGTCAGAGGGCTACTGCAGCCGTATCCTGCGCGCCCAGGGCACGCGGCGCGAGGGCTACACCGAGTTCAGCCTCCGCGTGGAGGGCGACCCCGACTTCTACAAGCCGGGAACCAGCTACCGCGTAACACTTTCAGCTGCTCCTCCCTCCTACTTCAGAGGATTCACATTAATTGCCCTCAGAGAGAACAGAGAGGGTGATAAGGAAGAAGACCATGCTGGGACCTTCCAGATCATAGACGAAGAAGAAACTCAGTTTATGAGCAATTGCCCTGTTGCAGTCACTGAAAGCACTCCACGGAGGAGGACCCGGATCCAGGTGTTTTGGATAGCACCACCAGCGGGAACAGGCTGCGTGATTCTGAAGGCCAGCATCGTACAAAAACGCATTATTTATTTTCAAGATGAGGGCTCTCTGACCAAGAAACTTTGTGAACAAGATTCCACATTTGATGGGGTGACTGACAAACCCATCTTAGACTGCTGTGCCTGCGGAACTGCCAAGTACAGACTCACATTTTATGGGAATTGGTCCGAGAAGACACACCCAAAGGATTACCCTCGTCGGGCCAACCACTGGTCTGCGATCATCGGAGGATCCCACTCCAAGAATTATGTACTGTGGGAATATGGAGGATATGCCAGCGAAGGCGTCAAACAAGTTGCAGAATTGGGCTCACCCGTGAAAATGGAGGAAGAAATTCGACAACAGAGTGATGAGGTCCTCACCGTCATCAAAGCCAAAGCCCAATGGCCAGCCTGGCAGCCTCTCAACGTGAGAGCAGCACCTTCAGCTGAATTTTCCGTGGACAGAACGCGCCATTTAATGTCCTTCCTGACCATGATGGGCCCTAGTCCCGACTGGAACGTAGGCTTATCTGCAGAAGATCTGTGCACCAAGGAATGTGGCTGGGTCCAGAAGGTGGTGCAAGACCTGATTCCCTGGGACGCTGGCACCGACAGCGGGGTGACCTATGAGTCACCCAACAAACCCACCATTCCCCAGGAGAAAATCCGGCCCCTGACCAGCCTGGACCATCCTCAGAGTCCTTTCTATGACCCAGAGGGTGGGTCCATCACTCAAGTAGCCAGAGTTGTCATCGAGAGAATCGCACGGAAGGGTGAACAATGCAATATTGTACCTGACAATGTCGATGATATTGTAGCTGACCTGGCTCCAGAAGAGAAAGATGAAGATGACACCCCTGAAACCTGCATCTACTCCAACTGGTCCCCATGGTCCGCCTGCAGCTCCTCCACCTGTGACAAAGGCAAGAGGATGCGACAGCGCATGCTGAAAGCACAGCTGGACCTCAGCGTCCCCTGCCCTGACACCCAGGACTTCCAGCCCTGCATGGGCCCTGGCTGCAGTGACGAAGACGGCTCCACCTGCACCATGTCCGAGTGGATCACCTGGTCGCCCTGCAGCATCTCCTGCGGCATGGGCATGAGGTCCCGGGAGAGGTATGTGAAGCAGTTCCCGGAGGACGGCTCCGTGTGCACGCTGCCCACTGAGGAAACGGAGAAGTGCACGGTCAACGAGGAGTGCTCTCCCAGCAGCTGCCTGATGACCGAGTGGGGCGAGTGGGACGAGTGCAGCGCCACCTGCGGCATGGGCATGAAGAAGCGGCACCGCATGATCAAGATGAACCCCGCAGATGGCTCCATGTGCAAAGCCGAGACATCACAGGCAGAGAAGTGCATGATGCCAGAGTGCCACACCATCCCATGCTTGCTGTCCCCATGGTCCGAGTGGAGTGACTGCAGCGTGACCTGCGGGAAGGGCATGCGAACCCGACAGCGGATGCTCAAGTCTCTGGCAGAACTTGGAGACTGCAATGAGGATCTGGAGCAGGTGGAGAAGTGCATGCTCCCTGAATGCCCCATTGACTGTGAGCTCACCGAGTGGTCCCAGTGGTCGGAATGTAACAAGTCATGTGGGAAAGGCCACGTGATTCGAACCCGGATGATCCAAATGGAGCCTCAGTTTGGAGGTGCACCCTGCCCAGAGACTGTGCAGCGAAAAAAGTGCCGCATCCGAAAATGCCTTCGAAATCCATCCATCCAAAAGCTACGCTGGAGGGAGGCCCGAGAGAGCCGGCGGAGTGAGCAGCTGAAGGAAGAGTCTGAAGGGGAGCAGTTCCCAGGTTGTAGGATGCGCCCATGGACGGCCTGGTCAGAATGCACCAAACTGTGCGGAGGTGGAATTCAGGAACGTTACATGACTGTAAAGAAGAGATTCAAAAGCTCCCAGTTTACCAGCTGCAAAGACAAGAAGGAGATCAGAGCATGCAATGTTCATCCTTGTTAG
ORF Protein Sequence MRLSPAPLKLSRTPALLALALPLAAALAFSDETLDKVPKSEGYCSRILRAQGTRREGYTEFSLRVEGDPDFYKPGTSYRVTLSAAPPSYFRGFTLIALRENREGDKEEDHAGTFQIIDEEETQFMSNCPVAVTESTPRRRTRIQVFWIAPPAGTGCVILKASIVQKRIIYFQDEGSLTKKLCEQDSTFDGVTDKPILDCCACGTAKYRLTFYGNWSEKTHPKDYPRRANHWSAIIGGSHSKNYVLWEYGGYASEGVKQVAELGSPVKMEEEIRQQSDEVLTVIKAKAQWPAWQPLNVRAAPSAEFSVDRTRHLMSFLTMMGPSPDWNVGLSAEDLCTKECGWVQKVVQDLIPWDAGTDSGVTYESPNKPTIPQEKIRPLTSLDHPQSPFYDPEGGSITQVARVVIERIARKGEQCNIVPDNVDDIVADLAPEEKDEDDTPETCIYSNWSPWSACSSSTCDKGKRMRQRMLKAQLDLSVPCPDTQDFQPCMGPGCSDEDGSTCTMSEWITWSPCSISCGMGMRSRERYVKQFPEDGSVCTLPTEETEKCTVNEECSPSSCLMTEWGEWDECSATCGMGMKKRHRMIKMNPADGSMCKAETSQAEKCMMPECHTIPCLLSPWSEWSDCSVTCGKGMRTRQRMLKSLAELGDCNEDLEQVEKCMLPECPIDCELTEWSQWSECNKSCGKGHVIRTRMIQMEPQFGGAPCPETVQRKKCRIRKCLRNPSIQKLRWREARESRRSEQLKEESEGEQFPGCRMRPWTAWSECTKLCGGGIQERYMTVKKRFKSSQFTSCKDKKEIRACNVHPC

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-SE1317-Ab Anti-SPON1/ VSGP/F-spondin/ f-spondin functional antibody
    Target Antigen GM-Tg-g-SE1317-Ag SPON1 protein
    ORF Viral Vector pGMLP001799 Human SPON1 Lentivirus plasmid
    ORF Viral Vector vGMLP001799 Human SPON1 Lentivirus particle


    Target information

    Target ID GM-SE1317
    Target Name SPON1
    Gene ID 10418, 233744, 699833, 64456, 101094373, 476864, 282866, 100056137
    Gene Symbol and Synonyms D330035F22Rik,f-spondin,FSP,SPON1,Sponf,VSGP/F-spondin
    Uniprot Accession Q9HCB6
    Uniprot Entry Name SPON1_HUMAN
    Protein Sub-location Secreted Protein/Potential Cytokines
    Category Not Available
    Disease Ovary Cancer
    Gene Ensembl ENSG00000262655
    Target Classification Not Available

    Predicted to be an extracellular matrix structural constituent. Predicted to be involved in cell adhesion. Predicted to act upstream of or within positive regulation of protein binding activity; positive regulation of protein processing; and regulation of amyloid precursor protein catabolic process. Located in extracellular space. Colocalizes with collagen-containing extracellular matrix. [provided by Alliance of Genome Resources, Apr 2022]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.